Industry collaborators
MayMag Biologics collaborates with world-class pharmaceutical manufacturers and API suppliers to deliver resilient, high-quality supply chains for biologics, biosimilars, and sterile injectables.
Our manufacturing capabilities are strengthened by strategic relationships with leading global pharmaceutical companies. These partnerships ensure continuous access to high-purity APIs, advanced biosimilar formulations, and cutting-edge manufacturing technologies.
Together, we support the global mission of making essential medicines more accessible, reliable, and affordable for patients worldwide.
Biosimilar & Insulin API Manufacturer
One of the world's most prominent fully integrated biopharmaceutical enterprises, Biocon Biologics delivers world-class biosimilar and recombinant insulin API manufacturing capacity — including insulin glargine, insulin lispro, and monoclonal antibodies — for regulated markets across North America, Europe, and emerging economies.
Insulin Analog API Manufacturer
A pioneering biopharmaceutical manufacturer specializing in the development, fermentation, and commercial-scale production of insulin analogs and biosimilar APIs — including insulin glargine, insulin lispro, and insulin aspart — designed for seamless sterile fill-finish operations.
Global Biosimilar & Generic Drug Leader
A global leader in generic and biosimilar pharmaceuticals, Sandoz develops and manufactures a broad portfolio of complex medicines — including biosimilar biologics and sterile injectables — serving patients in more than 100 countries with affordable, high-quality alternatives to reference drugs.
Sterile Injectable & Biopharmaceutical Manufacturer
A global pharmaceutical and biotechnology company with FDA-approved manufacturing facilities, Wockhardt specializes in sterile injectables, biosimilars, and novel drug delivery systems — providing high-quality pharmaceutical products to regulated markets across the US, UK, and Europe.
Custom Peptide API & CDMO Partner
Leveraging high-capacity cGMP synthetic and bioprocessing facilities, Yifan Pharmaceutical provides extensive custom contract development and API manufacturing solutions — specializing in complex peptide synthesis, biological API process optimization, and large-scale commercial supply for international regulated markets.
GMP Peptide API Exporter
Operating FDA- and EDQM-inspected facilities, APINO Pharma focuses on the custom manufacturing and global export of GMP-grade peptide and biosimilar APIs — including semaglutide, tirzepatide, and retatrutide — providing agile, regulatory-compliant active bulk substances for injectable therapies.
We are always open to exploring new collaborations with pharmaceutical manufacturers, API suppliers, and healthcare distributors who share our commitment to quality, compliance, and patient access.
Get in Touch